Old Web
English
Sign In
Acemap
>
authorDetail
>
Willem Remme
Willem Remme
Indian Institute of Technology Delhi
Heart failure
Internal medicine
Cardiology
Medicine
Spironolactone
4
Papers
5201
Citations
0.04
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
2003
The New England Journal of Medicine
Bertram Pitt
Willem Remme
Faiez Zannad
James D. Neaton
Felipe Martinez
Barbara Roniker
Richard Bittman
Steve Hurley
Jay Kleiman
Marjorie Gatlin
Show All
Source
Cite
Save
Citations (4103)
EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION
2003
Bertram Pitt
Willem Remme
Faiez Zannad
James D. Neaton
Felipe Martinez
Barbara Roniker
Richard Bittman
Steve Hurley
Jay Kleiman
Marjorie Gatlin
Show All
Source
Cite
Save
Citations (751)
Economic Evaluation of the Randomized Aldactone Evaluation Study (RALES): Treatment of Patients with Severe Heart Failure
2002
Cardiovascular Drugs and Therapy
Henry A. Glick
Sean M. Orzol
Joseph F. Tooley
Willem Remme
Shigetake Sasayama
Bertram Pitt
Show All
Source
Cite
Save
Citations (38)
The EPHESUS trial : Eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction
2001
Cardiovascular Drugs and Therapy
Bertram Pitt
Gordon I. Williams
Willem Remme
Felipe Martinez
Jose Lopez-Sendon
Faiez Zannad
James D. Neaton
Barbara Roniker
Steve Hurley
Dan Burns
Richard Bittman
Jay Kleiman
Show All
Source
Cite
Save
Citations (309)
1